Dec. 19, 2024

The Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) is requesting comments regarding questions that explore allowing nurse practitioners and physician assistants to be eligible to take the NIOSH B Reader examination to become certified B Readers. 

B Readers classify chest radiographic images of workers exposed to coal mine dust, crystalline silica, or asbestos for pneumoconiosis surveillance programs, such as the NIOSH Coal Workers' Health Surveillance Program. Currently, only physicians licensed to practice in the United States who have passed the examination can become certified B Readers. The examination was developed by NIOSH and the American College of Radiology® (ACR®) to test physicians’ ability to apply the International Labour Organization (ILO) classification system to chest radiographs.

ACR intends to file comments in response to NIOSH’s questions. To provide input for ACR’s consideration, contact Michael Peters, ACR Senior Director, Government Affairs. To provide public comments directly to NIOSH, carefully review the agency’s questions and provide feedback online.

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more